Table 2 SIRT characteristics
Per treatment (n = 36) | Per lesion (n = 43) | ||
|---|---|---|---|
< 120 Gy (n = 15) | ≥ 120 Gy (n = 28) | ||
SIRT localization (Mean 90Y-injected) | |||
Right | 20 (56%) (1148 MBq) | 12 (80%) | 13 (46%) |
Left | 11 (31%) (901 MBq) | 2 (13%) | 9 (32%) |
Whole | 4 (11%) (1675 MBq) | 1 (6%) | 5 (18%) |
Segmental | 1 (3%) (1940 MBq) | 0 | 1 (4%) |
Complications | |||
Moderate | 1 (3%) | ||
Tumour number | |||
Single | 12 (33%) | ||
Multiple | 24 (67%) | ||
Tumour response (4-month mRECIST) | |||
Complete response | 3 (83%) | 2 (13%) | 2 (7%) |
Partial response | 14 (39%) | 4 (27%) | 15 (54%) |
Stable disease | 6 (17%) | 2 (13%) | 5 (18%) |
Progressive disease | 13 (36%) | 7 (47%) | 6 (21%) |
Objective response† | 17 (53%) | 6 (40%) | 17 (61%) |
Disease control†† | 23 (67%) | 8 (53%) | 22 (79%) |